The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population

Immunobiology

Volumn 214, Issue 5, 2009, Pages 392-402

  Wu, Ou ^a   Chen, Guo Ping ^a   Chen, Hong ^a   Li, Xiang Pei ^b   Xu, Jian Hua ^a   Zhao, Shu Shan ^b   Sheng, Jun ^b   Feng, Jin Bao ^a   Cai, Jin ^a   Fang, Xue Hui ^a   Zhang, Wen Hui ^a   Li, Lian Hong ^a   Zhang, Ning ^a   Li, Jing ^a   Li, Jia Jia ^a   Pan, Fa Ming ^a   Wang, Chang Zhong ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

B lymphocytes; Lupus erythematosus; Systemic; T lymphocytes; T bet; Toll like receptor 9

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR T BET;

ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD19; ANTIGENS, CD3; B-LYMPHOCYTES; CELL SEPARATION; CHINA; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 64049093899     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.10.004     Document Type: Article

References (35)

1. Ayash-Rashkovsky M., Bentwich Z., and Borkow G. TLR9 expression is related to immune activation but is impaired in individuals with chronic immune activation. Int. J. Biochem. Cell Biol. 37 (2005) 2380
2. Boes M., Schmidt T., Linkemann K., Beaudette B.C., Marshak-Rothstein A., and Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97 (2000) 1184
3. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35 (1992) 630
4. Chan R.W., Lai F.M., Li E.K., Tam L.S., Chow K.M., Li P.K., and Szeto C.C. Expression of T-bet, a type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare. Rheumatology (Oxford) 46 (2007) 44
5. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202 (2005) 321
6. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., and Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203 (2006) 553
7. Fossati-Jimack L., Cortes-Hernandez J., Norsworthy P.J., Walport M.J., Cook H.T., and Botto M. C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice. Mol. Immunol. 45 (2008) 787
8. Gelman A.E., Zhang J., Choi Y., and Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol. 172 (2004) 6065
9. Gerth A.J., Lin L., and Peng S.L. T-bet regulates T-independent IgG2a class switching. Int. Immunol. 15 (2003) 937
10. Gu L., Weinreb A., Wang X.P., Zack D.J., Qiao J.H., Weisbart R., and Lusis A.J. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161 (1998) 6999
11. Hahn B.H. Antibodies to DNA. N. Engl. J. Med. 338 (1998) 1359
12. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
13. Hron J.D., and Peng S.L. Type I IFN protects against murine lupus. J. Immunol. 173 (2004) 2134
14. Isenberg D.A., Katz D., Le Page S., Knight B., Tucker L., Maddison P., Hutchings P., Watts R., Andre-Schwartz J., and Schwartz R.S. Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor?. J. Immunol. 147 (1991) 4172
15. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., Gilbert D., and Musette P. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J. Immunol. 177 (2006) 1349-1354
16. Leiter E.H., Serreze D.V., and Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol. Today 11 (1990) 147
17. Lit L.C., Wong C.K., Li E.K., Tam L.S., Lam C.W., and Lo Y.M. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 34 (2007) 89
18. Liu N., Ohnishi N., Ni L., Akira S., and Bacon K.B. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4 (2003) 687
19. Macfarlane D.E., and Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160 (1998) 1122
20. Martin R.M., Brady J.L., and Lew A.M. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J. Immunol. Methods 212 (1998) 187
21. Migita K., Miyashita T., Maeda Y., Nakamura M., Yatsuhashi H., Kimura H., Ishibashi H., and Eguchi K. Toll-like receptor expression in lupus peripheral blood mononuclear cells. J. Rheumatol. 34 (2007) 493
22. Mosca M., Chimenti D., Pratesi F., Baldini C., Anzilotti C., Bombardieri S., and Migliorini P. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J. Rheumatol. 33 (2006) 695
23. Nakano S., Morimoto S., Suzuki J., Nozawa K., Amano H., Tokano Y., and Takasaki Y. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford) 47 (2008) 145
24. Nishihara M., Terada M., Kamogawa J., Ohashi Y., Mori S., Nakatsuru S., Nakamura Y., and Nose M. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42 (1999) 2616
25. Oelzner P., Deliyska B., Funfstuck R., Hein G., Herrmann D., and Stein G. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus-relationship with disease activity and renal involvement. Clin. Rheumatol. 22 (2003) 271
26. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., Raptopoulou A., Kritikos H.D., Mamalaki C., Sidiropoulos P., and Boumpas D.T. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 54 (2006) 3601
27. Peng S.L. The T-box transcription factor T-bet in immunity and autoimmunity. Cell. Mol. Immunol. 3 (2006) 87
28. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229
29. Santaella M.L., Cox P.R., Colon M., Ramos C., and Disdier O.M. Rheumatologic manifestations in patients with selected primary immunodeficiencies evaluated at the University Hospital. P. R. Health Sci. J. 24 (2005) 191
30. Tao K., Fujii M., Tsukumo S., Maekawa Y., Kishihara K., Kimoto Y., Horiuchi T., Hisaeda H., Akira S., Kagami S., and Yasutomo K. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann. Rheum. Dis. 66 (2007) 905
31. Trouw L.A., Seelen M.A., Duijs J.M., Benediktsson H., Van Kooten C., and Daha M.R. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin. Exp. Immunol. 132 (2003) 32
32. Vidal S., Kono D.H., and Theofilopoulos A.N. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101 (1998) 696
33. Watson M.L., Rao J.K., Gilkeson G.S., Ruiz P., Eicher E.M., Pisetsky D.S., Matsuzawa A., Rochelle J.M., and Seldin M.F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176 (1992) 1645
34. Wu X., and Peng S.L. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum. 54 (2006) 336
35. Yu P., Musette P., and Peng S.L. Toll-like receptor 9 in murine lupus: more friend than foe!. Immunobiology 213 (2008) 151